Zilberberg, M. D., Nathanson, B. H., Sulham, K., Fan, W., & Shorr, A. F. (2017). 30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: A retrospective cohort study. Antimicrob Resist Infect Control.

Zilberberg, Marya D., Brian H. Nathanson, Kate Sulham, Weihong Fan, ja Andrew F. Shorr. "30-day Readmission, Antibiotics Costs and Costs of Delay to Adequate Treatment of Enterobacteriaceae UTI, Pneumonia, and Sepsis: A Retrospective Cohort Study." Antimicrob Resist Infect Control 2017.

Zilberberg, Marya D., et al. "30-day Readmission, Antibiotics Costs and Costs of Delay to Adequate Treatment of Enterobacteriaceae UTI, Pneumonia, and Sepsis: A Retrospective Cohort Study." Antimicrob Resist Infect Control 2017.